PIK3C2A and Hyperbilirubinemia: To the best of our knowledge, there have been no reported cases of atorvastatin-induced γ-glutamyl transpeptidase (GGT) elevation in the absence of hyperbilirubinemia, hypertransaminasemia, and serum creatine phosphokinase (CPK) abnormalities.